Effect of End-Stage Kidney Disease Factor on the Sedative Effects of Ciprofol
Dandan Sun, Mingming Han, Xiang Huang, Danjun Lu, Bingqing Zhu, Daoying Zhou, Muzi Hua, Fang Kang, Juan Li · 2026
Read Effect of End-Stage Kidney Disease Factor on the Sedative Effects of Ciprofol by Dandan Sun, Mingming Han, Xiang Huang, Danjun Lu, Bingqing Zhu, Daoying Zhou, Muzi Hua, Fang Kang, Juan Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13265006.txt.
Description
Dandan Sun and a large team wrote a 2026 study on whether end-stage kidney disease changes how the sedative ciprofol works. The drug is used in general anesthesia, and failing kidneys can alter drug handling, so dosing for transplant patients needs proof. They compared kidney transplant patients on dialysis with matched patients whose kidneys worked normally.
Using a dose step-up and step-down method, they found the dose needed to stop response to airway device placement was the same in both groups. Drug use during surgery, waking times, and blood pressure and heart stability also matched. Side effects like low blood pressure, slow heart rate, and slowed breathing occurred at like rates. The authors conclude that kidney failure does not meaningfully change this drug's sedative effect or safety.
Catalog record
| CREATOR | Dandan Sun, Mingming Han, Xiang Huang, Danjun Lu, Bingqing Zhu, Daoying Zhou, Muzi Hua, Fang Kang, Juan Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26319 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |